harmacare
Discussion and Debate
The Pharmaceutical Industry and the Canadian Government: Folie à Deux
Joel Lexchin
Discussion and Debate
A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada
Steven G. Morgan, Marc-André Gagnon, Barbara Mintzes and Joel Lexchin
Research Paper
How Safe and Innovative Are First-in-Class Drugs Approved by Health Canada: A Cohort Study
Joel Lexchin
Discussion and Debate
A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada
Steven G. Morgan, Marc-André Gagnon, Barbara Mintzes and Joel Lexchin
Editorial
From the Editors
Discussion and Debate
A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada
Steven G. Morgan, Marc-André Gagnon, Barbara Mintzes and Joel Lexchin
Research Paper
Some Numbers behind Canada’s Decision to Adopt an Orphan Drug Policy: US Orphan Drug Approvals in Canada, 1997–2012
Matthew Herder and Timothy Mark Krahn